thought 2.75 would be a good settling point but no the huge volume pulled it down further. biotech being very low today does not help either.
The only way we can see some light is if some insider goes ahead and makes some open market purchases at this point. If they are confident of their product I dont know what would prevent them from doing that. Wonder whether there is any point in giving the investor relations office a call? has anybody done that before?